Loss of LDOC1 Expression by Promoter Methylation in Cervical Cancer Cells

REFERENCES

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Available from: http://seer.cancer.gov/statfacts/html/cervix.html; June 2013.
   Google Scholar
• Available from: http://globocan.iarc.fr/factsheets/cancers/cervix. asp; June 2013.
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012;62:283–298.
   PubMed Web of Science ®Google Scholar
• Alfonso Dueñas-González A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005;4:38.
   PubMedGoogle Scholar
• Peltomäki P. Mutations and epimutations in the origin of cancer. Exp Cell Res 2012;318:299–310.
   PubMed Web of Science ®Google Scholar
• Lu Q, Ma D, Zhao S. DNA methylation changes in cervical cancers. Methods Mol Biol 2012;863:155–176.
   PubMedGoogle Scholar
• Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 1999;140:227–234.
   Google Scholar
• Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Mori R, Tomoda K, Katada T, Harada K, Fujii Y. Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis. Dis Esophagus 2008;21: 288–297.
   PubMed Web of Science ®Google Scholar
• Duzkale H, Schweighofer CD, Coombes KR, Barron LL, Ferrajoli A, O'Brien S, Wierda WG, Pfeifer J, Majewski T, Czerniak BA, Jorgensen JL, Medeiros LJ, Freireich EJ, Keating MJ, Abruzzo LV. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood 2011;117:4076–4084.
   PubMed Web of Science ®Google Scholar
• Lee CH, Wong TS, Chan JY, Lu SC, Lin P, Cheng AJ, Chen YJ, Chang JS, Hsiao SH, Leu YW, Li CI, Hsiao JR, Chang JY. Epigenetic regulation of the X-linked tumor suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. J Pathol 2013;230:298–309.
   PubMed Web of Science ®Google Scholar
• Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, Pertz LM, Clark RA, Schwartz S, Segraves R, Oseroff VV, Albertson DG, Pinkel D, Eichler EE. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 2005;77:78–88.
   PubMed Web of Science ®Google Scholar
• Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, Carpten JD, Trent JM, Schleutker J, Barrett JC, Jurka J, Larionov V. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res 2005;15:1477–1486.
   PubMed Web of Science ®Google Scholar
• Brüning A, Vogel M, Burger P, Rahmeh M, Gingelmaier A, Friese K, Lenhard M, Burges A. Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells. Biochem Biophys Res Commun 2008;377:1309–1314.
   PubMed Web of Science ®Google Scholar
• Brüning A. Analysis of nelfinavir-induced endoplasmic reticulum stress. Methods Enzymol 2011;491:127–142.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, Brüning A. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 2008;7:1460–1467.
   PubMedGoogle Scholar
• Inoue M, Takahashi K, Niide O, Shibata M, Fukuzawa M, Ra C. LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett 2005;579:604–608.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–764.
   PubMed Web of Science ®Google Scholar
• Löf-Öhlin ZM, Sorbe B, Wingren S, Nilsson TK. Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients. Int J Oncol 2011;39:683–688.
   PubMed Web of Science ®Google Scholar
• Sobti RC, Singh N, Hussain S, Suri V, Nijhawan R, Bharti AC, Bharadwaj M, Das BC. Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis. Cell Oncol 2011;34:533–543.
   PubMedGoogle Scholar
• Salemi M, Giuffrida D, Giuffrida MC, Soma PF, Rolfo A, Cimino L, Condorelli RA, Castiglione R, La Vignera S, Calogero AE. LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease. Tumori 2012;98:86e–88e.
   PubMedGoogle Scholar
• Salemi M, Soma PF, Bosco P, Vicari E, Roberto C, Calogero AE. CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease. Hum Cell 2013;26:128–130.
   PubMed Web of Science ®Google Scholar
• Mizutani K, Koike D, Suetsugu S, Takenawa T. WAVE3 functions as a negative regulator of LDOC1. J Biochem 2005;138:639–646.
   PubMed Web of Science ®Google Scholar
• Chih DY, Park DJ, Gross M, Idos G, Vuong PT, Hirama T, Chumakov AM, Said J, Koeffler HP. Protein partners of C/EBPepsilon. Exp Hematol 2004;32:1173–1181.
   PubMed Web of Science ®Google Scholar
• Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 2010;336:25–37.
   PubMed Web of Science ®Google Scholar
• Baldwin AS. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol Rev 2012;246:327–345.
   PubMed Web of Science ®Google Scholar
• Roossink F, de Jong S, Wisman GB, van der Zee AG, Schuuring E. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art. Cell Oncol 2012;35:231–241.
   PubMedGoogle Scholar